Maxicef-O 50mg Oral Suspension contains Cefixime 50mg, a third-generation cephalosporin antibiotic effective against a broad spectrum of gram-positive and gram-negative bacteria. It is indicated for the treatment of various bacterial infections including acute otitis media, pharyngitis, tonsillitis, uncomplicated urinary tract infections, and uncomplicated gonorrhea. Cefixime acts by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. Maxicef-O is formulated as an oral suspension, facilitating ease of administration, particularly in pediatric patients or those with difficulty swallowing tablets. The dosage and duration of therapy should be determined based on the severity of infection, patient age, and renal function. Common adverse effects may include gastrointestinal disturbances such as diarrhea, nausea, abdominal pain, and hypersensitivity reactions. Caution is advised in patients with a known allergy to cephalosporins or penicillins. Renal impairment may necessitate dosage adjustment. Maxicef-O should be used judiciously to minimize the development of antibiotic resistance. It is essential to complete the prescribed course even if symptoms improve early. This medication should be stored at controlled room temperature and reconstituted suspension should be used within the recommended timeframe to ensure efficacy and safety.